Wells Fargo Initiates Coverage On CME Group with Overweight Rating, Announces Price Target of $301
Wells Fargo analyst Daniel Welden initiates coverage on CME Group (NASDAQ:CME) with a Overweight rating and announces Price Target of $301.
Share
Why It Matters
A big bank analyst thinks CME Group is worth watching closely. They believe the stock could do well, so investors are paying attention.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.